Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Koenecke

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Ebiomedicine|July 11, 2020
Reappearance of effector T cells is associated with recovery from COVID-19Ivan Odak, Joana Barros-Martins, Berislav Bošnjak, et al.
Cell Reports|June 20, 2019
Single-Cell Transcriptomics Identifies the Adaptation of Scart1<sup>+</sup> Vγ6<sup>+</sup> T Cells to Skin Residency as Activated Effector CellsLikai Tan, Inga Sandrock, Ivan Odak, et al.
Haematologica|July 20, 2023
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemiaRabia Shahswar, Gernot Beutel, Razif Gabdoulline, et al.
Bone Marrow Transplantation|October 24, 2021
HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working PartyMalgorzata Mikulska, Olaf Penack, Lotus Wendel, et al.
Science Immunology|April 24, 2021
A fetal wave of human type 3 effector γδ cells with restricted TCR diversity persists into adulthoodLikai Tan, Alina Suzann Fichtner, Elena Bruni, et al.
Bone Marrow Transplantation|December 7, 2023
The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working PartyLars Klingen Gjærde, Tapani Ruutu, Christophe Peczynski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2014
Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working PartyMarie Robin, Annalisa Ruggeri, Myriam Labopin, et al.
Cancer|April 17, 2024
Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myelomaAttaya Suvannasankha, Nizar Bahlis, Suzanne Trudel, et al.
Frontiers in Immunology|April 1, 2022
Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of ConcernIvan Odak, Christian R Schultze-Florey, Swantje I Hammerschmidt, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2019
Immunization against poly-<i>N</i>-acetylglucosamine reduces neutrophil activation and GVHD while sparing microbial diversityJan Hülsdünker, Oliver S Thomas, Eileen Haring, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Ebiomedicine|July 11, 2020
Reappearance of effector T cells is associated with recovery from COVID-19Ivan Odak, Joana Barros-Martins, Berislav Bošnjak, et al.
Cell Reports|June 20, 2019
Single-Cell Transcriptomics Identifies the Adaptation of Scart1<sup>+</sup> Vγ6<sup>+</sup> T Cells to Skin Residency as Activated Effector CellsLikai Tan, Inga Sandrock, Ivan Odak, et al.
Haematologica|July 20, 2023
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemiaRabia Shahswar, Gernot Beutel, Razif Gabdoulline, et al.
Bone Marrow Transplantation|October 24, 2021
HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working PartyMalgorzata Mikulska, Olaf Penack, Lotus Wendel, et al.
Science Immunology|April 24, 2021
A fetal wave of human type 3 effector γδ cells with restricted TCR diversity persists into adulthoodLikai Tan, Alina Suzann Fichtner, Elena Bruni, et al.
Bone Marrow Transplantation|December 7, 2023
The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working PartyLars Klingen Gjærde, Tapani Ruutu, Christophe Peczynski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2014
Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working PartyMarie Robin, Annalisa Ruggeri, Myriam Labopin, et al.
Cancer|April 17, 2024
Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myelomaAttaya Suvannasankha, Nizar Bahlis, Suzanne Trudel, et al.
Frontiers in Immunology|April 1, 2022
Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of ConcernIvan Odak, Christian R Schultze-Florey, Swantje I Hammerschmidt, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2019
Immunization against poly-<i>N</i>-acetylglucosamine reduces neutrophil activation and GVHD while sparing microbial diversityJan Hülsdünker, Oliver S Thomas, Eileen Haring, et al.
Pageof 11